/Globe%20Life%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Globe Life has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
/Aon%20plc_%20office%20sign-%20by%20JHVEPhoto%20via%20Shutterstock.jpg)
Aon has underperformed the broader market over the past year, though analysts remain moderately optimistic about the company’s long-term growth outlook and earnings resilience.
/Metlife%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
MetLife has underperformed other insurance stocks over the past year, but analysts remain somewhat optimistic about the stock’s growth potential.
/Everest%20Group%20Ltd%20logo%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Although Everest Group has lagged the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
/Brown%20%26%20Brown%2C%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Brown & Brown has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
/W_R_%20Berkley%20Corp_%20phone%20and%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
While W. R. Berkley has outpaced the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
/Allstate%20Corp%20magnified%20logo-%20by%20ll_studio%20via%20Shutterstock.jpg)
Although Allstate has trailed the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
/Aon%20plc_%20bilboard-%20by%20monticello%20via%20Shutterstock.jpg)
While Aon has considerably underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Although Erie Indemnity has underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
/Aflac%20Inc_%20sign-%20by%20yu_photo%20via%20Shutterstock.jpg)
As Aflac has lagged the S&P 500 over the past year, Wall Street analysts remain cautious on the stock, reflecting tempered expectations for its near-term performance and growth outlook.